Event Brief
Jun 10, 2026 at 5:05 AM ET
CUHK study finds lorlatinib may keep advanced lung cancer stable
By The BriefBrief
A CUHK-led study reports lorlatinib can keep over half of advanced lung cancer patients alive without progression for at least seven years.
WHO: Chinese University of Hong Kong (CUHK) researchers
WHAT: Released findings from a global study on lorlatinib for advanced lung cancer
WHEN: Jun 10, 2026 at 4:03 AM ET
WHERE: Hong Kong
WHY: Researchers released the study results on the efficacy of the third-generation targeted therapy lorlatinib.
Reporting from 1 identified publisher for this event.
View all 1 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
US says drones intercepted over Jordan, Kuwait, Bahrain
Middle-East
Jun 10, 2026 at 5:05 AM ET
Cuba residents struggle to reach hospital amid fuel shortages
Asia-Pacific
Jun 10, 2026 at 5:05 AM ET
Iran says US and Israel violate ceasefire, hurt diplomacy
Iran
Jun 10, 2026 at 5:04 AM ET
Bystanders praised after knife attack in Belfast
Europe
Jun 10, 2026 at 5:04 AM ET
Page 16010 of 21417
Same format. Every time.
Continue reading — sign in or create a free account with
